Holdings of Edmond de Rothschild Fund - Healthcare
Edmond de Rothschild Asset Management (Luxembourg) · 42 declared positions · as of Mar 31, 2026
Fund report · Net assets 308.4M € · Ten largest lines: 43.8 % of net assets · Compare with another fund · Report an error
Positions
| Rank | Company | Currency | Shares | Value | Weight |
|---|---|---|---|---|---|
| 1 | ASTRAZENECA PLC Royaume-Uni | GBP | 108,160 | 18.2M € | 5.90 % |
| 2 | MERCK & CO. INC. États-Unis | USD | 170,080 | 17.8M € | 5.76 % |
| 3 | NOVARTIS AG-REG Suisse | CHF | 118,780 | 15.5M € | 5.03 % |
| 4 | ROCHE HOLDING AG Suisse | CHF | 41,660 | 14.2M € | 4.59 % |
| 5 | UCB SA Belgique | EUR | 51,720 | 13.4M € | 4.34 % |
| 6 | BIOMARIN PHARMACEUTICAL INC États-Unis | USD | 247,980 | 12.2M € | 3.94 % |
| 7 | DENTSPLY SIRONA INC États-Unis | USD | 1,128,300 | 11.4M € | 3.68 % |
| 8 | BEONE MEDICINES LTD-ADR États-Unis | USD | 43,430 | 11.2M € | 3.63 % |
| 9 | ARGENX SE Pays-Bas | EUR | 17,750 | 11M € | 3.57 % |
| 10 | MEDTRONIC PLC Irlande | USD | 138,250 | 10.4M € | 3.37 % |
| 11 | THERMO FISHER SCIENTIFIC INC États-Unis | USD | 23,960 | 10.2M € | 3.31 % |
| 12 | SIEMENS HEALTHINEERS AG Allemagne | EUR | 275,390 | 10M € | 3.24 % |
| 13 | UNITEDHEALTH GROUP INC États-Unis | USD | 42,080 | 9.9M € | 3.20 % |
| 14 | BIOGEN INC États-Unis | USD | 56,970 | 9.1M € | 2.94 % |
| 15 | IONIS PHARMACEUTICALS INC États-Unis | USD | 137,190 | 8.9M € | 2.90 % |
| 16 | LONZA GROUP AG-REG Suisse | CHF | 15,356 | 8.4M € | 2.71 % |
| 17 | BAXTER INTERNATIONAL INC États-Unis | USD | 569,590 | 8.3M € | 2.69 % |
| 18 | ABBOTT LABORATORIES États-Unis | USD | 90,970 | 8.1M € | 2.63 % |
| 19 | PFIZER INC États-Unis | USD | 325,100 | 7.9M € | 2.57 % |
| 20 | NOVO NORDISK A/S-B Danemark | DKK | 256,100 | 7.9M € | 2.57 % |
| 21 | GILEAD SCIENCES INC États-Unis | USD | 60,000 | 7.3M € | 2.35 % |
| 22 | BIONTECH SE-ADR Allemagne | USD | 92,310 | 7.1M € | 2.31 % |
| 23 | WUXI BIOLOGICS CAYMAN INC Chine | HKD | 1,630,200 | 6M € | 1.93 % |
| 24 | IQVIA HOLDINGS INC États-Unis | USD | 39,470 | 5.8M € | 1.89 % |
| 25 | COOPER COS INC/THE États-Unis | USD | 83,400 | 5.2M € | 1.68 % |
| 26 | DEXCOM INC États-Unis | USD | 94,350 | 5.1M € | 1.67 % |
| 27 | BRISTOL-MYERS SQUIBB CO États-Unis | USD | 97,500 | 5.1M € | 1.66 % |
| 28 | OXFORD NANOPORE TECHNOLOGIES Royaume-Uni | GBP | 3,804,200 | 4.8M € | 1.56 % |
| 29 | QIAGEN N.V. Pays-Bas | EUR | 129,645 | 4.5M € | 1.46 % |
| 30 | TANDEM DIABETES CARE INC États-Unis | USD | 258,200 | 4.3M € | 1.39 % |
| 31 | DENALI THERAPEUTICS INC États-Unis | USD | 225,680 | 3.8M € | 1.22 % |
| 32 | CENTENE CORP États-Unis | USD | 128,300 | 3.6M € | 1.18 % |
| 33 | SHANDONG WEIGAO GP MEDICAL-H Chine | HKD | 8,748,000 | 3.6M € | 1.18 % |
| 34 | AMUNDI FUNDS CASH USD I2 USD C Luxembourg | USD | 3,116 | 3.5M € | 1.14 % |
| 35 | GERON CORP États-Unis | USD | 2,330,000 | 3M € | 0.98 % |
| 36 | SONOVA HOLDING AG-REG Suisse | CHF | 13,800 | 2.7M € | 0.87 % |
| 37 | BOSTON SCIENTIFIC CORP États-Unis | USD | 46,540 | 2.5M € | 0.82 % |
| 38 | TECAN GROUP AG-REG Suisse | CHF | 16,800 | 2.4M € | 0.78 % |
| 39 | NATERA INC États-Unis | USD | 13,500 | 2.3M € | 0.76 % |
| 40 | NURIX THERAPEUTICS INC États-Unis | USD | 90,000 | 1.2M € | 0.39 % |
| 41 | AXOGEN INC États-Unis | USD | 31,800 | 914.4K € | 0.30 % |
| 42 | EDMOND DE ROTHSCHILD CREDIT VERY SHORT France | EUR | 2,050 | 280.6K € | 0.09 % |
Source: report published by Edmond de Rothschild Fund - Healthcare.
Country breakdown
- États-Unis 53.5 %
- Suisse 14.0 %
- Royaume-Uni 7.4 %
- Allemagne 5.5 %
- Pays-Bas 5.0 %
- Belgique 4.3 %
- Irlande 3.4 %
- Chine 3.1 %
- Danemark 2.6 %
- Luxembourg 1.1 %
- France 0.1 %
The countries are those of the fund report. Weights are in % of net assets.
Currency breakdown
- USD 60.3 %
- CHF 14.0 %
- EUR 12.7 %
- GBP 7.4 %
- HKD 3.1 %
- DKK 2.6 %
Each line is counted in its quoted currency, as the fund declares it.
Cite this page
Titelia. "Holdings of Edmond de Rothschild Fund - Healthcare". https://titelia.com/en/funds/edmond-de-rothschild-fund-healthcare